Showing posts with label Industrial Biotechnology. Show all posts
Showing posts with label Industrial Biotechnology. Show all posts

Monday, 18 November 2013

Insulin Production From the Milk of Argentine Cow Clones

1. INTRODUCTION:

1.1 Insulin

Insulin is a peptide hormone made of 51 amino acids composing two chains A and B. The A chain has 21 amino acids and the B chain has 30 amino acids. The two chains are linked by intra and inter disulphide linkages. The release of this hormone is mainly initiated by the blood glucose levels.

1.2 Diabetes Mellitus

The inability of the 2-cells of Langerhans to secrete adequate or inability to secrete insulin following the glucose load is said to be Diabetes mellitus. The complications of diabetes are Cataract formation, Acute to Chronic renal failure, Cardiac problems, unhealed wounds, Mycoses etc.

Due to the above said complications, it has impacts on the living standards of people. The worldwide diabetic population is about 200 million. The WHO data reveal that this will become doubled by 2025 ( based on 2002 data ). This implies the importance of this hormone.

1.3 History of Insulin

Baunting and Best developed the use of insulin therapy in 1921. Insulin was the first protein to be sequenced by Frederick Sanger in 1950s. For about 60 years diabetics were dependent on natural sources of insulin with attendant problems of supply and quality. In the late 1970s and early 1980s recombinant DNA technology enabled scientists to synthesis insulin in bacteria.

The best natural source of insulin is human insulin which can be isolated in crystalline form from the cadaver of human. It costs approximately about 5000$ per vial, which is practically impossible. As diabetes affects irrational of sex, race, economic status which led scientists to think of alternate techniques that will bring down the production cost. Using plasmid vectors, scientists produce insulin from E.coli by rDNA technology. It has its own advantages and disadvantages. It has low generation time but the chances for contamination are high.

2. TRANSGENIC ANIMALS

Generation of transgenic animals is complex in terms of both technical difficulty and ethical problems.

2.1 Utilisation of Transgenic Animals to Produce Proteins

The use of transgenic animals to produce the proteins of human interest was already in practice. One of such example is production of tissue Plasminogen Activator (tPA) in the milk of goats. Here the mammary control DNA and coding DNA for tissue plasminogen activator are utilized to produce rDNA. The hybrid gene is inoculated in to fertilized egg ( isolated from a goat ) by microinjection. The microinjected fertilized egg is transferred to a foster mother. Then the hybrid gene carriers were mate to produce the transgenic female homozygous for the transgene. This transgenic technology enables goats to secrete tPA in milk. A similar technique with little modifications is used to make cows secrete insulin in milk. 2.2 Procedure

Here the animal selected is Jersey heifer which is known for its abundant milk production. The mammary control DNA of Jersey heifer fetus is isolated. In animals and Plants, the DNA to Protein ratio is less. Hence the nuclei isolated first. This increases the ratio of DNA to Protein and avoids contamination of chromosomal DNA by DNA from cytoplasmic organelles. The nuclei opened , the RNA and Protein are enzymatically digested, then the DNA is precipitated.

o The coding DNA for human insulin is isolated in the same manner.

o It is then treated with type II Restriction Endonucleases to cut at specific sites.

o The required DNA sequences are joined together using DNA ligase enzymes.

o The hybrid gene is introduced in to the cell by microinjection. Once the gene enters the cell should enter the nucleus.

o The Jersey heifer's eggs are taken and the nucleus is removed using a micropipette.

o The genetically modified nuclei are fused with enucleated eggs using cloning techniques.

o The electrical stimulus cause cell dividing and an early embryo is developed.

o The embryo cells are separated and are implanted in surrogate mother cows.

o It gives rise to 4 genetically modified calves in 385 ± 5 days.

o These calves will reach maturity in 18 - 24 months at which they are capable of producing milk.

o Once they start producing milk, the insulin can be obtained by purification and refining of milk using protein purification techniques like HPLC.

- Scientists isolated the specific cell types from Jersey heifer's fetus from a slaughter house

- The rDNA is introduced in to the cell which reaches the nucleus

- The genetically modified nuclei is fused with enucleated cattle eggs using cloning techniques

- The electrical impulse starts cell division

- The cells are individualized and can be implanted into 4 surrogate mother cows

- The mother cow will give birth to genetically modified calves in 385 ± 5 days

- The genetically modified calves will reach adulthood in 18 - 24 months

- Once they start milk production, the insulin can be obtained by purification and refining of milk.

3. Conclusion

o This technique will definitely can reduce the production cost by atleast 30%.

o The complications can be overcome by further working with this.

o This will definitely cause a revolution in the utilization of transgenic animals for protein production if the usual difficulties are solved.

4. BIBLIOGRAPHY

Google search

BIOTECHNOLOGY Mohan. P. Arora ( 2004) Himalaya Publishing House

GENETIC ENGINEERING Desmond S. T. Nicholl, Paisley ( 2002 ) Cambridge University Press

MOLECULAR BIOTECHNOLOGY- Principles and Applications of Recombinant DNA Bernard R. Glick and Jack J. Pasternak ( 2002 )

Article Source: http://EzineArticles.com/?expert=Abdul_Rasheed_S
http://EzineArticles.com/?Insulin-Production-From-the-Milk-of-Argentine-Cow-Clones&id=1925683

Saturday, 13 July 2013

Information on Biotech Companies

Biotech companies are those that make use of biotechnology for producing goods and services. They make use of science, chemicals etc for the manufacture of their products. There are several biotech companies across the globe. These companies like all other companies have to be approved by the government to start operating. There is a list of biotech companies on the internet. They solely operate on organism related to biology. Their research is base on organisms and the equipments used by them are much more different than the other completely different form the other companies.

Usually not all biotech companies make a huge profit. Study says that only one out of ten of these companies earn profits. They aim at improving the standard of life of people unlike other companies. Due to recessions the funding for these companies had been stopped due the deterioration in funds. The funds required by them is considerably large because their research in done on trial and error basis to attain the required results. New biotech companies are being opened and they are recruiting expert staff for delivering products and services to the people.

These companies blend science and engineering together to get their work done. They focus on the welfare of the society and are involved in the production of drugs, foodstuff, recycling, etc. There are divided into three sections industrial biotechnology, agricultural biotechnology and medical biotechnology. They staff recruited by them are highly educated in either science or engineering and sometimes both. These companies are continuously working towards finding cures for the different types of harmful diseases that are known to cause irreparable damage.

If you are looking for a career in biotechnology then you first need to decide which field you want to get into. The you can get your research done on the internet to find the best universities that provide education for the required field. Once you get your decrees there are several companies that provide internships so that you are expertly trained for the job you have applied for.

The funding for new biotech companies are still on a hold up to some extent because banks have issued a limit on private funding. If the products manufactured by these are of the right quality and are very beneficial to the people then these companies become popular and their demand increases. Like other companies they too have to make expenses on promotion and advertisement. The government should make arrangements for giving them capital as in turn they may also benefit if the company starts making a considerable amount of profit.

Scientists aim at earning an income by making living life easy for the other. Their research is based humans, plants, animal, and all other living organisms. It is being predicted that in the near future these companies will find cures for disease like cancer, tuberculosis, AID's etc. They continue functioning for the benefit of the society even if the profits earned by them are very low.

One of the hard hits of the recent economic recession has been the slow-down of private funding for new biotech companies. With a general haze of uncertainty hovering in the economic climate, comes an apprehensive attitude toward emergent industry.

Article Source: http://EzineArticles.com/?expert=Alvaro_Buckley
http://EzineArticles.com/?Information-on-Biotech-Companies&id=5474144

Wednesday, 3 July 2013

Biotech Venture Capital Fund

Biotech venture capital fund opportunities have come as a big boon for entrepreneurs wanting to develop new drugs and disease treatments. They are lucrative because they get a better inside view of all living organisms. These require funds and they are not easily available from traditional lending agencies. The creditors we know about are hardwired to certain set systems and conditions and do not want to move away from them.

Surefire profits

Biotech ventures span a wide gamut as they can be about animal, human and industrial biotechnology. It includes products and services and depending on your aptitude, you would be looking for the right area where you can make money. And making surefire profits with new and out of the box ideas are also the quickest way to get funding for your project. You could also be developing biosensors, biotech equipment and pharmaceuticals.

Nowadays, the traditional investors have taken a back seat as they do not want to park their funds in new and what they think are risky ventures. But you can get all help from biotech venture capital fund managers as they are not only willing to take risks as they have an eye for out of the box ideas that can bear fruit, but also offer hands on help to get you on track. New ventures in the area of biotech are not only promising, but they offer a wide range of growth opportunities as well.

The reason is for everyone to see as biotech venture capital fund topped the list with nearly $639 million for 66 companies. Financing for biotech ventures have gone up 14 percent on the back of increased demand for such industries. Fund managers are also excited about the profits that can be generated in the new arena of medical devices and life sciences.

Great opportunity as an entrepreneur

You have a great opportunity as an entrepreneur in these fields because the baby boomer generation has started to age and they are afflicted with a host of diseases. The new types of diseases have made the interest in biotech grow much more in the last few years. Infectious diseases are a great concern and have also led to a surge in development of newer ways of combating them.

To cure them, new and more advanced vaccines are required that are backed by cutting edge research. To fuel investments, biotech venture capital fund is the only way out. Venture funds are also finding the emergence of this new medical research area lucrative as profits are coming in fast for entrepreneurs who have managed to get in early.

Fund that were parked elsewhere before the economic downturn are also coming in as fund managers are fast realizing the potential of biotech in generating surefire profits. You can get a survey done and also avail of useful information and comparative analysis of other companies using biotech venture capital fund well.

Visit http://www.ventureworthy.com/Biotech-venture-capital-fund.asp to find more on Biotech venture capital fund and how to start with it.

Article Source: http://EzineArticles.com/?expert=Vincent_Irwin
http://EzineArticles.com/?Biotech-Venture-Capital-Fund&id=6350571

Friday, 26 April 2013

BIOCHEMICAL ENGINEERING-CAREER GUIDANCE

TOPICS TO BE STUDIED ON INTERNET IN TEXTS AND IMAGES Chemical engineering and Biological engineering Bioreactor Industrial biotechnology Biological hydrogen ...

Monday, 11 February 2013

Modes of Fermentation

Reference: Industrial Biotechnology. Sustainable Growth and Economic Success. Edited by Wim Soetaert and Erick J. Vandamme Modes of Fermentation batch culture, fed- batch and continuous culture fermentation

Best Books in Biotechnology